Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death

Abstract

Seven CPVT and four SQTS genes have valid evidence for disease causation and should be included in genetic testing panels. Additional genes associated with conditions that may mimic clinical features of CPVT/SQTS have potential utility for differential diagnosis.